Compare PSIX & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSIX | PRGO |
|---|---|---|
| Founded | 1985 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | N/A | 1991 |
| Metric | PSIX | PRGO |
|---|---|---|
| Price | $63.03 | $13.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $98.76 | $22.50 |
| AVG Volume (30 Days) | 506.2K | ★ 3.7M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 8.83% |
| EPS Growth | ★ 122.27 | N/A |
| EPS | ★ 5.26 | N/A |
| Revenue | $675,481,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $48.27 | N/A |
| Revenue Next Year | $14.25 | N/A |
| P/E Ratio | $11.97 | ★ N/A |
| Revenue Growth | ★ 54.78 | N/A |
| 52 Week Low | $15.30 | $12.17 |
| 52 Week High | $121.78 | $30.93 |
| Indicator | PSIX | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.56 | 33.32 |
| Support Level | $60.49 | $12.93 |
| Resistance Level | $62.26 | $13.63 |
| Average True Range (ATR) | 3.82 | 0.43 |
| MACD | 2.21 | 0.29 |
| Stochastic Oscillator | 76.69 | 44.25 |
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.